Suppr超能文献

mdm2和p53在结直肠上皮性肿瘤中的表达。

Expression of mdm2 and p53 in epithelial neoplasms of the colorectum.

作者信息

Hao X P, Günther T, Roessner A, Price A B, Talbot I C

机构信息

Academic Department of Pathology, Northwick Park and St Mark's NHS Trust, Harrow, UK.

出版信息

Mol Pathol. 1998 Feb;51(1):26-9. doi: 10.1136/mp.51.1.26.

Abstract

AIMS

To evaluate the respective roles of mdm2 (murine double minute 2) and p53 in the development of colorectal carcinoma.

METHODS

Formalin fixed, paraffin wax embedded tissues from 72 sporadic adenomas and 55 carcinomas were investigated by means of immunohistochemistry for mdm2 and p53.

RESULTS

mdm2 was expressed weakly in 17 of 72 (23.6%) adenomas and in 14 of 55 (25.4%) carcinomas. p53 was expressed in 19 of 72 (26.4%) adenomas and in 23 of 55 (41.8%) carcinomas. Four adenomas and five carcinomas showed positive staining for both proteins. Overexpression of p53 in adenomas was associated with moderate and severe dysplasia but not with tumour size. No associations were found between the expression of mdm2 and either the degree of dysplasia or tumour size. In carcinomas, neither the expression of p53 nor mdm2 correlated with Dukes's stage, metastasis, or differentiation. No associations were found between the expression of p53 and mdm2 in either adenomas or carcinomas.

CONCLUSIONS

Although mdm2 has been reported to be an oncogene, it does not appear to play a major role in the development of colorectal carcinoma.

摘要

目的

评估mdm2(小鼠双微体2)和p53在结直肠癌发生发展中的各自作用。

方法

采用免疫组织化学方法对72例散发性腺瘤和55例癌组织的福尔马林固定、石蜡包埋组织进行mdm2和p53检测。

结果

mdm2在72例腺瘤中的17例(23.6%)和55例癌中的14例(25.4%)呈弱表达。p53在72例腺瘤中的19例(26.4%)和55例癌中的23例(41.8%)呈表达。4例腺瘤和5例癌两种蛋白均呈阳性染色。腺瘤中p53的过表达与中重度发育异常相关,但与肿瘤大小无关。mdm2的表达与发育异常程度或肿瘤大小均无相关性。在癌组织中,p53和mdm2的表达均与Dukes分期、转移或分化无关。腺瘤或癌组织中p53和mdm2的表达之间均无相关性。

结论

尽管mdm2已被报道为一种癌基因,但它似乎在结直肠癌的发生发展中不起主要作用。

相似文献

1
Expression of mdm2 and p53 in epithelial neoplasms of the colorectum.
Mol Pathol. 1998 Feb;51(1):26-9. doi: 10.1136/mp.51.1.26.
2
MDM2/p53 protein expression in the development of colorectal adenocarcinoma.
J Gastrointest Surg. 2000 Jan-Feb;4(1):109-14. doi: 10.1016/s1091-255x(00)80041-4.
4
Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance.
Cancer. 1996 Jan 15;77(2):255-64. doi: 10.1002/(SICI)1097-0142(19960115)77:2<255::AID-CNCR6>3.0.CO;2-L.
5
Expression of p53 and mdm2 mRNA and protein in colorectal carcinomas.
Eur J Cancer. 1999 Jul;35(7):1083-8. doi: 10.1016/s0959-8049(99)00058-1.
6
Expression of Bcl-2 and p53 in the colorectal adenoma-carcinoma sequence.
Pathobiology. 1997;65(3):140-5. doi: 10.1159/000164115.

引用本文的文献

1
Association of Murine Double Minute 2 Genotypes and Lung Cancer Risk.
In Vivo. 2020 May-Jun;34(3):1047-1052. doi: 10.21873/invivo.11874.
2
Contribution of Murine Double Minute 2 Genotypes to Colorectal Cancer Risk in Taiwan.
Cancer Genomics Proteomics. 2018 Sep-Oct;15(5):405-411. doi: 10.21873/cgp.20099.
3
Current evidence on the relationship between SNP309 polymorphism in the MDM2 gene and colorectal cancer risk.
Tumour Biol. 2013 Dec;34(6):3721-9. doi: 10.1007/s13277-013-0956-z. Epub 2013 Aug 3.
4
MDM2 gene amplification and protein expressions in colon carcinoma: is targeting MDM2 a new therapeutic option?
Virchows Arch. 2011 Feb;458(2):197-203. doi: 10.1007/s00428-010-1012-7. Epub 2010 Nov 27.
6
MDM2 overexpression with alteration of the p53 protein and gene status in oral carcinogenesis.
Jpn J Cancer Res. 2000 May;91(5):492-8. doi: 10.1111/j.1349-7006.2000.tb00972.x.
7
MDM2/p53 protein expression in the development of colorectal adenocarcinoma.
J Gastrointest Surg. 2000 Jan-Feb;4(1):109-14. doi: 10.1016/s1091-255x(00)80041-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验